Search terms
Results 1 - 10 of 42 - ordered by :
Pages: 1 2 3 4 5 ... 5

Optimal handling of the healthy In the preventive section, the HOPE-3 (Heart Outcomes Prevention Evaluation 3) trial stole the limelight, first and foremost by strengthening faith in statinsthis time ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Manan Pareek, Deepak L. Bhatt

Date : 01/07/2016 Item size : 164372 bytes

Communications from regulators such as the US Food and Drug Administration concerning potential side effects of statin therapy (particularly memory loss and the risk of diabetes) have created debate ...

European Heart Journal, Clinical update, Muh Geot Wong, Christoph Wanner, John Knight, Vlado Perkovic

Date : 14/11/2015

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast The field of percutaneous coronary intervention (PCI) remains extremely active and fruitful, with major advances involving ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/01/2016

Methods and results Randomized controlled trial data from the Women's Health Study were used to predict treatment effects for individual women in terms of absolute risk reduction for major ...

European Heart Journal, Dorresteijn, Johannes A.N., Visseren, Frank L.J., Ridker, Paul M, Paynter, Nina P., Wassink, Annemarie M.J., Buring, Julie E., van der Graaf, Yolanda, Cook, Nancy R.

Date : 01/12/2011 Item size : 225787 bytes

[...]there has been a call for newer avenues for risk reduction. Many organisms have been implicated, including herpesviruses, Chlamydia pneumoniae, Mycoplasma pneumoniae, periodontal pathogens, and ...

European Heart Journal, Natarajan, Pradeep, Cannon, Christopher P.

Date : 01/07/2011

In this multi-centre, randomized, double blind trial picotamide, a dual inhibitor of thromboxane A2 synthase and receptor, was compared with aspirin for the prevention of mortality and major ...

European Heart Journal, Neri Serneri, Gian Gastone, Coccheri, Sergio, Marubini, Ettore, Violi, Francesco

Date : 01/10/2004

Risk factors were age over 65 years, male gender [hazard ratio (HR) 1.2], previous MI (HR 1.5), previous stroke and/or peripheral vascular disease (HR 1.7), diabetes, smoking, angina (all HR 1.5), ...

European Heart Journal, Deckers, Jaap W., Goedhart, Dick M., Boersma, Eric, Briggs, Andrew, Bertrand, Michel, Ferrari, Roberto, Remme, Willem J., Fox, Kim, Simoons, Maarten L.

Date : 01/04/2006 Item size : 176909 bytes

See doi:10.1016/j.ehj.2003.10.033for the article to which this editorial refers In this issue Ostergren et al.1studied the prognostic importance of the ankle-brachial index (ABI) and the risk ...

European Heart Journal, Duprez, Daniel

Date : 01/01/2004

[...]PAD has rapidly transformed from a largely overlooked condition, managed solely by a 5-word prescription (stop smoking and go walking), to a disease requiring multi-therapeutic interventions and ...

European Heart Journal, Gresele, Paolo, Migliacci, Rino

Date : 01/10/2004 Item size : 107568 bytes

At present, 3040% of all German patients >65 years are prescribed four or more different medications, and this number is expected to increase.1,2 Non-adherence to medical treatments is an ...

European Heart Journal, Laufs, Ulrich, Rettig-Ewen, Volker, Böhm, Michael

Date : 01/02/2011